Trial intelligence / Profile preview

Naltrexone for lichen planopilaris

IRCT20180809040747N1Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of naltrexone in lichen planopilaris (LPP), sponsored by Tehran University of Medical Sciences. Started Apr 2018; status: completed.

02

Drugs

naltrexone
03

Conditions

lichen planopilaris (LPP)

Beyond the preview

Go deeper on IRCT20180809040747N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180809040747N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call